Mathieu Laversanne

156.5k citations
60 papers · 97.8k indexed · 18 hit papers · h-index 35

Impact in

  • Cancer Research top 0.01%
    • Cancer-related molecular mechanisms research
    • Cancer, Lipids, and Metabolism
  • Oncology top 0.01%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Screening and Detection

Papers in

Mathieu Laversanne

54 papers receiving 96.8k citations

Hit Papers

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries 2024 · 10.0k citations
10.0k201420262018202220.0k40.0k60.0k

Peers

Mathieu Laversanne
Comparison fields: 5 of 215
  • Cancer Research 20.8k
  • Oncology 35.4k
  • Pulmonary and Respiratory Medicine 26.7k
  • Hepatology 4.7k
  • Otorhinolaryngology 2.1k
Replace Hyuna Sung with:
Hyuna Sung United States
Lindsey A. Torre United States
David Forman United Kingdom
Elizabeth Ward United States
Donald Maxwell Parkin France
Kimberly D. Miller United States
Adrian L. Harris United Kingdom
Ralph H. Hruban United States
Carlo La Vecchia Italy
Isabelle Soerjomataram France
Mathieu Laversanne relative to Hyuna Sung United States Hyuna Sung's profile →
Citations per field
00.5×7.6×
Hyuna Sung · 1×
Citations per year

Countries citing papers authored by Mathieu Laversanne

Since Specialization
Citations

This map shows the geographic impact of Mathieu Laversanne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Laversanne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Laversanne more than expected).

Fields of papers citing papers by Mathieu Laversanne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Laversanne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Laversanne. The network helps show where Mathieu Laversanne may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mathieu Laversanne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mathieu Laversanne Line = papers co-authored together Mathieu Laversanne links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
Hit paper breakdown →
2024183
4 20241
5 202435
6
Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data
Hit paper breakdown →
202463
7 202333
8 20239
9 202318
10
Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020
Hit paper breakdown →
2022156
11 202238
12
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN
Hit paper breakdown →
20221082
13
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Hit paper breakdown →
20221688
14
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Hit paper breakdown →
202172442
15 202133
16
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012
Hit paper breakdown →
2020184
17
International trends in hepatocellular carcinoma incidence, 1978–2012
Hit paper breakdown →
2019392
18 201672
19 2015116
20
International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
Hit paper breakdown →
2014705

About Mathieu Laversanne

Mathieu Laversanne is a scholar working on Oncology, Organizational Behavior and Human Resource Management, Reproductive Medicine, Epidemiology and Otorhinolaryngology, having authored 60 papers that have together received 97.8k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (25 papers), Colorectal Cancer Screening and Detection (17 papers), Esophageal Cancer Research and Treatment (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Multiple and Secondary Primary Cancers (6 papers), Global Public Health Policies and Epidemiology (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Cancer Research (20.8k citations), Oncology (35.4k citations), Pulmonary and Respiratory Medicine (26.7k citations), Hepatology (4.7k citations) and Otorhinolaryngology (2.1k citations). Mathieu Laversanne has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Freddie Bray, Isabelle Soerjomataram, Ahmedin Jemal, Jacques Ferlay, Hyuna Sung, Rebecca L. Siegel, Melina Arnold, Mónica S. Sierra, Jérôme Vignat and Elisabete Weiderpass. Their work appears in journals such as International Journal of Cancer, JNCI Journal of the National Cancer Institute, Cancer Epidemiology, European Urology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026